Clinical Trial 22461

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies

Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia

PI: Nishihori, Taiga

Clinical Trial 22464

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: A Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)

Disease Site: Thyroid

PI: Agosto Salgado, Sarimar

Clinical Trial 23101

Disease Site: Other Hematopoietic

PI: Fernandez, Hugo

Clinical Trial 20571

Optimizing Cellular and Humoral Immunity to Pneumococcus by Vaccination with Pneumococcal 13-valent conjugate vaccine before and after CD19-targeted CAR T-cell Immunotherapy

Disease Site: Lymphoma, Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 21193

Disease Site: Brain and Nervous System, Brain metastasis

PI: Yu, Hsiang-Hsuan (Michael)

Clinical Trial 20897

Phase 1 Dose-Escalation, Dose-Expansion Trial of Intratumoral HER2- and HER3-Primed Dendritic Cells Injections for the Treatment of Early-Stage TNBC and ER Low Positive Breast Cancer (DecipHER)

Disease Site: Breast

PI: Costa, Ricardo

Clinical Trial 21416

A Phase 1, Open-label, Preliminary Pharmacokinetics (PK) and Safety Study of CLN-049 (An fms-like tyrosine kinase 3 [FLT3] x cluster of differentiation 3 [CD3] bispecific T cell engager) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Disease Site: Myeloid and Monocytic Leukemia

PI: Chan, Onyee

Clinical Trial 21559

Disease Site: Prostate

PI: Zhang, Jingsong

Clinical Trial 21621

A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects with Relapsed/Refractory Follicular Lymphoma

Disease Site: Non-Hodgkin's Lymphoma

PI: Gaballa, Sameh

Clinical Trial 21996

Disease Site: Other Skin

PI: Khushalani, Nikhil

Clinical Trial 22102

A Phase 1b, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants with Solid Tumors

Disease Site: Breast, Other Female Genital, Ovary

PI: Han, Heather

Clinical Trial 22112

A Phase 1, Open-Label, Dose Escalation and Expansion Study of CUE-102 Monotherapy in HLA-A*0201 Positive Patients with WTl Positive Recurrent/Metastatic Cancers

Disease Site: Esophagus, Other Digestive Organ

PI: Kim, Dae Won